Alterações na eficácia e segurança em pacientes com síndrome de Lennox-Gastaut que passam do ensaio controlado randomizado com fenfluramina para o estudo aberto de extensão
NeurologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Epilepsia open
- Publicado em
- 3 ago 2026
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Changes in effectiveness and safety in patients with Lennox-Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open-label extension study
Rima Nabbout, Orrin Devinsky, Lieven Lagae, Ingrid Eileen Scheffer, Renzo Guerrini, Joseph Sullivan, Antonio Gil-Nagel, Sameer M Zuberi, Kate Riney, Patrick Healy et al.
Descritores MeSH
- Lennox Gastaut Syndrome
- Anticonvulsants
- Fenfluramine
- Seizures
- Double-Blind Method
- Female
- Treatment Outcome
- Humans
- Male
- Adolescent
Veja também
Estudos relacionados
- Safety and efficacy of eslicarbazepine acetate for seizure prevention in patients with stroke at high risk of developing post-stroke epilepsy: a proof-of-concept, phase 2a, randomised, double-blind, placebo-controlled antiepileptogenesis trial
- Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregivers
- Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study
- Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical Trial